Schisandrin B - CAS 61281-37-6
Catalog number: 61281-37-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C23H28O6
Molecular Weight:
400.46
COA:
Inquire
Targets:
Others
Description:
Schisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae, has been shown to produce antioxidant effect on rodent liver and heart.
Purity:
>98%
Synonyms:
Sch B
MSDS:
Inquire
InChIKey:
RTZKSTLPRTWFEV-UHFFFAOYSA-N
InChI:
InChI=1S/C23H28O6/c1-12-7-14-9-16(24-3)20(25-4)22(26-5)18(14)19-15(8-13(12)2)10-17-21(23(19)27-6)29-11-28-17/h9-10,12-13H,7-8,11H2,1-6H3
Canonical SMILES:
CC1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4CC1C)OC)OC)OC)OC)OCO3
1.Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo.
Leong PK1, Ko KM1. Biofactors. 2015 Sep-Oct;41(5):314-23. doi: 10.1002/biof.1224. Epub 2015 Aug 26.
Reactive oxygen species (ROS)-mediated activation of inflammasome is involved in the development of a wide spectrum of diseases. We aimed to investigate whether (-)schisandrin B [(-)Sch B], a phytochemical that can induce cellular antioxidant response, can suppress the inflammasome activation. Results showed that (-)Sch B can induce an nuclear factor erythroid 2-related factor 2-driven thioredoxin expression in primary peritoneal macrophages and cultured RAW264.7 macrophages. A 4-h priming of peritoneal macrophages with LPS followed by a 30-min incubation with ATP caused the activation of caspase 1 and the release of IL-1β, indicative of inflammasome activation. Although LPS/ATP did not activate inflammasome in RAW264.7 macrophages, it caused the ROS-dependent c-Jun N-terminal kinase1/2 (JNK1/2) activation and an associated lactate dehydrogenase (LDH) release in RAW264.7 macrophages, an indication of cytotoxicity. (-)Sch B suppressed the LPS/ATP-induced activation of caspase 1 and release of IL-1β in peritoneal macrophages.
2.Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Cai Z1, Liu J2, Bian H3, Cai J1, Zhu G1. Arch Pharm Res. 2016 Apr;39(4):499-507. doi: 10.1007/s12272-016-0713-0. Epub 2016 Jan 29.
The aim of the present study was to assess the effects and mechanisms of Schisandrin B (SchB) on lipopolysaccharide (LPS)-induced acute lung injury (ALI). ALI was induced in mice by intratracheal instillation of LPS (1 mg/kg), and SchB (25, 50, and 75 mg/kg) was injected 1 h before LPS challenge by gavage. After 12 h, bronchoalveolar lavage fluid (BALF) samples and lung tissues were collected. Histological studies demonstrated that SchB attenuated LPS-induced interstitial edema, hemorrhage, and infiltration of neutrophils in the lung tissue. SchB pretreatment at doses of 25, 50, and 75 mg/kg was shown to reduce LPS-induced lung wet-to-dry weight ratio and lung myeloperoxidase activity. In addition, pretreatment with SchB lowered the number of inflammatory cells and pro-inflammatory cytokines including tumor necrosis factor-α, interleukin-1β, and interleukin-6 in BALF. The mRNA and protein expression levels of nuclear factor kappa B (NF-κB) signaling-related molecules activated by P2X7 were investigated to determine the molecular mechanism of SchB.
3.Correction: A Naturally-Derived Compound Schisandrin B Enhanced Light Sensation in the pde6c Zebrafish Model of Retinal Degeneration.
Zhang L, Xiang L, Liu Y, Venkatraman P, Chong L, Cho J, Bonilla S, Jin ZB, Pang CP, Ko KM, Ma P, Zhang M, Leung YF. PLoS One. 2016 Apr 25;11(4):e0154552. doi: 10.1371/journal.pone.0154552.
[This corrects the article DOI: 10.1371/journal.pone.0149663.].
4.A Naturally-Derived Compound Schisandrin B Enhanced Light Sensation in the pde6c Zebrafish Model of Retinal Degeneration.
Zhang L1, Xiang L2,1, Liu Y3, Venkatraman P1, Chong L1, Cho J1, Bonilla S1, Jin ZB2, Pang CP4, Ko KM5, Ma P2, Zhang M6, Leung YF1,7. PLoS One. 2016 Mar 1;11(3):e0149663. doi: 10.1371/journal.pone.0149663. eCollection 2016.
Retinal degeneration is often progressive. This feature has provided a therapeutic window for intervention that may extend functional vision in patients. Even though this approach is feasible, few promising drug candidates are available. The scarcity of new drugs has motivated research to discover novel compounds through different sources. One such example is Schisandrin B (SchB), an active component isolated from the five-flavor fruit (Fructus Schisandrae) that is postulated in traditional Chinese medicines to exert prophylactic visual benefit. This SchB benefit was investigated in this study in pde6cw59, a zebrafish retinal-degeneration model. In this model, the pde6c gene (phosphodiesterase 6C, cGMP-specific, cone, alpha prime) carried a mutation which caused cone degeneration. This altered the local environment and caused the bystander rods to degenerate too. To test SchB on the pde6cw59 mutants, a treatment concentration was first determined that would not cause morphological defects, and would initiate known physiological response.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 14277-97-5 Domoic acid

Domoic acid
(CAS: 14277-97-5)

Domoic acid is an excitatory amino acid and has been found to be a kainate receptor agonist.

CAS 1783816-74-9 NVS-PAK1-1

NVS-PAK1-1
(CAS: 1783816-74-9)

NVS-PAK1-1 is potent and specific allosteric PAK1 inhibitor (IC50= 5 nM) with selective over PAK2 and a panel of 442 kinases.

CAS 68941-21-9 SKF 91488 dihydrochloride

SKF 91488 dihydrochloride
(CAS: 68941-21-9)

SKF 91488 dihydrochloride is a potent inhibitor of histamine N-methyltransferase with no histamine agonist activity. SKF 91488 is used in the treatment of depre...

CAS 36341-25-0 YL-109

YL-109
(CAS: 36341-25-0)

Mice treated with vehicle showed significantly enlarged tumors, whereas mice treated with YL-109 showed attenuated tumor growth using MCF-7 cells. Interestingly...

CAS 5581-42-0 Glyparamide

Glyparamide
(CAS: 5581-42-0)

Glyparamide is a chlorophenyl-containing sulfonylurea with hypoglycemic activity and rarely causes hepatic injury.

CAS 858128-57-1 SPB

SPB
(CAS: 858128-57-1)

SPB is a key component of pulmonary surfactant which lowers surface tension in the lungs.

CAS 70381-44-1 CH 150

CH 150
(CAS: 70381-44-1)

CH 150 is a bio-active chemical, but detailed information has not been published.

CAS 60166-93-0 Iopamidol

Iopamidol
(CAS: 60166-93-0)

Iopamidol is a nonionic, low-osmolar iodinated contrast agent, developed by Bracco.

Chemical Structure

CAS 61281-37-6 Schisandrin B

Quick Inquiry

Verification code

Featured Items